Debora Collotta and Massimo Collino (2016) “NLRP3 Inflammasome Signaling Platform as New Pharmacological Target for Metaflammation”, Diabetes Research, 3(1), pp. e1-e3. doi: 10.17140/DROJ-3-e008.